Rational engineering of cholesterol-modified prodrug nanoassemblies for improving the tumor selectivity and safety of mitoxantrone DOI Creative Commons
Bowen Zhang, Wenyuan Liu, Jinrui Liu

и другие.

Fundamental Research, Год журнала: 2024, Номер unknown

Опубликована: Июнь 1, 2024

Mitoxantrone (MTO) is an anthraquinone antitumor drug with potent therapeutic benefits. However, its clinical application restricted by the severe side effects stemming from poor tumor selectivity. In this study, MTO and cholesterol (CLS) were conjugated via a tumor-selective disulfide bond to obtain MTO-SS-CLS prodrug. Interestingly, could self-assemble into uniform nanoassemblies, addition of DSPE-PEG2K significantly improved self-assembly behavior stability. Moreover, compared solutions, bond-bridged nanoassemblies exhibited heightened selectivity pharmacokinetic properties. addition, prodrug tolerated dose safety without compromising effect. This research enriches pharmaceutical paves way for extensive application.

Язык: Английский

A computer-aided, heterodimer-based “triadic” carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency DOI
Liyan Yang, Yingying Zhang,

Yuxin Lai

и другие.

Journal of Colloid and Interface Science, Год журнала: 2024, Номер 677, С. 523 - 540

Опубликована: Авг. 14, 2024

Язык: Английский

Процитировано

8

Hybrid adipocyte-derived exosome nano platform for potent chemo-phototherapy in targeted hepatocellular carcinoma DOI
Xinying Liu, Jiaxin Zhang,

Shunzhe Zheng

и другие.

Journal of Controlled Release, Год журнала: 2024, Номер 370, С. 168 - 181

Опубликована: Апрель 24, 2024

Язык: Английский

Процитировано

7

Disulfide/α-Amide-Bridged Doxorubicin Dimeric Prodrug: Effect of Aggregation Structures on pH/GSH Dual-Triggered Drug Release DOI
Yang Chen, Peng Liu

Langmuir, Год журнала: 2024, Номер 40(21), С. 11098 - 11105

Опубликована: Май 13, 2024

Disulfide bonding has attracted intense interest in the tumor intracellular microenvironment-activated drug delivery systems (DDSs) last decades. Although various molecular structures of redox-responsive disulfide-containing DDSs have been developed, no investigation was reported on effect aggregation structures. Here, pH/GSH dual-triggered release investigated with simplest doxorubicin-based self-delivery system (DSDS), disulfide/α-amide-bridged doxorubicin dimeric prodrug (DDOX), as a model. By fast precipitation or slow self-assembly, DDOX nanoparticles were obtained. With similar diameters, they exhibited different releases, demonstrating The π–π stacking degrees revealed by UV–vis, fluorescence, and BET analysis nanoparticles. between its activated products also explored simulation approach. finding opens new ideas design high-performance for future precise treatment.

Язык: Английский

Процитировано

7

Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapy DOI Creative Commons
Yaqiao Li, Lingxiao Li, Qianhui Jin

и другие.

Asian Journal of Pharmaceutical Sciences, Год журнала: 2022, Номер 17(2), С. 241 - 252

Опубликована: Фев. 27, 2022

PEGylation has been widely used to improve the pharmacokinetic properties of prodrug self-assembled nanoparticles (prodrug-SANPs). However, impacts amount PEG on self-assemble stability, cellular uptake, pharmacokinetics, and antitumor efficacy prodrug-SANPs are still unknown. Herein, selenoether bond bridged docetaxel dimeric was synthesized as model prodrug. Five were designed by using different mass ratios prodrugs (Wprodrug/WDSPE-mPEG2000 = 10:0, 9:1, 8:2, 7:3 6:4), defined Pure drug NPs, 9:1NPs, 8:2NPs, NPs 6:4 respectively. Interestingly, 8:2 formed most compact nanostructure, thus improving stability pharmacokinetics behavior. In addition, difference these in uptake investigated, influence cytotoxicity also clarified details. The exhibited much better than other even commercial product. Our findings demonstrated pivotal role prodrug-SANPs.

Язык: Английский

Процитировано

28

Insights into stimuli-responsive diselenide bonds utilized in drug delivery systems for cancer therapy DOI Open Access

Zhenfeng Shi,

Jifang Liu, Lei Tian

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2022, Номер 155, С. 113707 - 113707

Опубликована: Сен. 16, 2022

Due to the complexity and particularity of cancer cell microenvironments, redox responsive drug delivery systems (DDSs) for therapy have been extensively explored. Compared with widely reported treatment based on disulfide bonds, diselenide bonds better properties greater anticancer efficiency. In this review, significance application in DDSs are summarized, stimulation sensitivity is comprehensively reported. The potential prospects next-generation discussed.

Язык: Английский

Процитировано

27

Cabazitaxel prodrug nanoassemblies with branched chain modifications: Narrowing the gap between efficacy and safety DOI

Hezhen Xu,

Shiyi Zuo, Danping Wang

и другие.

Journal of Controlled Release, Год журнала: 2023, Номер 360, С. 784 - 795

Опубликована: Июль 22, 2023

Язык: Английский

Процитировано

16

Rational Engineering Docetaxel Prodrug Nanoassemblies: Response Modules Guiding Efficacy Enhancement and Toxicity Reduction DOI
Danping Wang, Lingxiao Li,

Hezhen Xu

и другие.

Nano Letters, Год журнала: 2023, Номер 23(8), С. 3549 - 3557

Опубликована: Апрель 13, 2023

Prodrug-based nanoassemblies have been developed to solve the bottlenecks of chemotherapeutic drugs. The fabricated prodrugs usually consist active drug modules, response and modification modules. Among three modules play a vital role in controlling intelligent release at tumor sites. Herein, various locations disulfide bond linkages were selected as construct Docetaxel (DTX) prodrugs. Interestingly, small structural difference caused by length endowed corresponding prodrug with unique characteristic. α-DTX-OD nanoparticles (NPs) possessed advantages high redox-responsiveness due their shortest linkages. However, they too sensitive retain intact structure blood circulation, leading severe systematic toxicity. β-DTX-OD NPs significantly improved pharmacokinetics DTX but may induce damage liver. In comparison, γ-DTX-OD longest greatly ameliorated delivery efficiency well DTX's tolerance dose.

Язык: Английский

Процитировано

15

The effect of lengths of branched-chain fatty alcohols on the efficacy and safety of docetaxel-prodrug nanoassemblies DOI Creative Commons
Shuo Wang, Tian Liu,

Yuetong Huang

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2023, Номер 14(3), С. 1400 - 1411

Опубликована: Сен. 30, 2023

The self-assembly prodrugs are usually consisted of drug modules, activation and assembly modules. Keeping the balance between efficacy safety by selecting suitable modules remains a challenge for developing prodrug nanoassemblies. This study designed four docetaxel (DTX) using disulfide bonds as different lengths branched-chain fatty alcohols (C16, C18, C20, C24). determined ability affected modules' sensitivity. extension carbon chains improved prodrugs' pharmacokinetic behavior while reducing cytotoxicity increased cumulative toxicity. use C20 can safety. These results provide great reference rational design

Язык: Английский

Процитировано

14

Recent Advances in Engineering Prodrug-based Nanomedicines for Cancer Therapy DOI Creative Commons
Linlin Shi, Shanshan Lin,

Fengping Zhou

и другие.

Materials Advances, Год журнала: 2024, Номер 5(11), С. 4634 - 4659

Опубликована: Янв. 1, 2024

This review focuses on updates regarding a broad spectrum of fabrication advances and applications in the field prodrug-based nanotechnologies multiple cancer therapeutic strategies response to tumor microenvironment.

Язык: Английский

Процитировано

6

Engineering Paclitaxel Prodrug Nanoparticles via Redox-Activatable Linkage and Effective Carriers for Enhanced Chemotherapy DOI

Shaojin Lu,

Rui Xia, Jian Wang

и другие.

ACS Applied Materials & Interfaces, Год журнала: 2021, Номер 13(39), С. 46291 - 46302

Опубликована: Сен. 24, 2021

The current clinical performance of chemotherapy is far from satisfactory, greatly limited by insufficient delivery efficacy and serious systemic side effects. Dimeric prodrug systems are emerging as valuable strategies for boosting the antitumor outcome. Here, dimeric paclitaxel prodrugs were synthesized with different bridged linkers, formed nanoparticles possessed excellent colloidal stability ultrahigh drug content. diselenide bond containing could respond to a redox-heterogeneous intracellular microenvironment on-demand release subsequently show selective cytotoxicity toward tumor cells against normal cells. Furthermore, optimal carrier materials screened out according their contribution on stability, endocytosis, cytotoxicity, biodistribution, efficacy. Compared DSPE-PEG, human serum albumin, Fe-tannic acid-based complex, F127 anchored nanoformulations exhibited preferential accumulation potent anticancer effect. Our present work provides deep insight into development advanced comprehensive advantages enhancing cancer therapy.

Язык: Английский

Процитировано

30